Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 245 recruiting now early-phase tilt #5 of 28,707 conditions

Depression: early-phase trial registry

245 of 687 indexed Depression trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5 of 28,707 conditions by registered trial count.

687 US clinical trials · 245 currently recruiting · #5 of 28,707 conditions by registered trial count

Depression: 687 US clinical trials tracked, 245 recruiting.

Depression is the subject of 687 registered US clinical trials on ClinicalTrials.gov, 245 of them currently open to new participants. 70 are in Phase 3-4 (later-stage) and 111 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 29 of these trials.

Enrollment posture brief

Registry condition depression

OPEN 245 | RECR 36% | LATE 70 | EARLY 111 | RANK #5 | SPON 29

Nearest open-share peer: Pancreatic Cancer (36% recruiting · 283 trials)

Cancer44.9%Prostate Cancer36.7%Depression (this)36%Hypertension32.2%HIV Infections9.1%
Open-enrollment share among volume-matched conditions near Depression

Depression lists 245 open slots (36% of 687 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Depression on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Depression recruits in line with its size-band peers.

    245 of 687 indexed trials (35.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Depression trials is spread across many organizations.

    Massachusetts General Hospital accounts for 29 of 687 trials (4.2%). 231 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depression enrolment sits around 100 participants.

    Median target enrolment is 100 among the 680 trials that report a genuine target (sentinel values excluded). 331 of those (48.7%) plan for fewer than 100 participants.

  4. Depression research is mostly interventional.

    618 interventional and 69 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 141Phase 270Phase 329Phase 441

Open and recent trials

687 total, page 13 of 14

COMPLETED NA 31 participants

e-Mindfulness for Depression in Older Adults

Washington University School of Medicine

NCT03922217

COMPLETED NA 30 participants

Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients

Nationwide Children's Hospital

NCT01822197

COMPLETED NA 30 participants

Investigating Central Neurophysiologic Correlates of Non-Motor Symptoms of Parkinson's Disease

University of North Carolina, Chapel Hill

NCT05205772

COMPLETED NA 30 participants

Improving Care of Patients With Heart Failure

University of California, San Francisco

NCT01461681

COMPLETED NA 30 participants

Mindfulness for Breast Cancer

NYU Langone Health

NCT02647216

COMPLETED NA 30 participants

Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications

University of Pittsburgh

NCT02384590

COMPLETED Phase 1 30 participants

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Joshua Woolley

NCT02950467

COMPLETED Phase 3 30 participants

Frontline Clinician Psilocybin Study

University of Washington

NCT05163496

COMPLETED Phase 2 29 participants

Beating the Blues for Your Heart

Indiana University

NCT01605552

COMPLETED NA 29 participants

Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes

University of California, San Diego

NCT02330627

COMPLETED Phase 2 29 participants

SAM-e for the Treatment of Depression in Patients With Parkinson's Disease

NYU Langone Health

NCT00070941

COMPLETED 29 participants

Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)

Mayo Clinic

NCT01299337

COMPLETED Phase 4 29 participants

Duloxetine for Menopausal Depression

Massachusetts General Hospital

NCT01117857

COMPLETED Phase 4 26 participants

A Study of Sertraline to Prevent PTSD

Massachusetts General Hospital

NCT00182078

COMPLETED NA 26 participants

UCSF TARA Study: Training for Awareness, Resilience and Action

University of California, San Francisco

NCT02480257

COMPLETED NA 26 participants

Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Stanford University

NCT05525390

COMPLETED NA 25 participants

Increasing Physical Activity in Persons With Depression

University of Texas Southwestern Medical Center

NCT02781688

COMPLETED Phase 2 25 participants

A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression

Orexigen Therapeutics

NCT00624858

COMPLETED NA 25 participants

Financial Incentives to Improve Medication Adherence

Northwell Health

NCT04191876

COMPLETED Phase 4 25 participants

Study of Naltrexone-Induced Blockade of Antidepressant Effects

Marta Peciña, MD PhD

NCT04322526

COMPLETED Phase 4 25 participants

Ketamine for Depression: An MRI Study

Massachusetts General Hospital

NCT02544607

COMPLETED Phase 2 24 participants

Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects

Boston University

NCT00322309

COMPLETED NA 24 participants

Concurrent Treatment for Depressed Parents and DepressedAdolescents

Brown University

NCT00951821

COMPLETED NA 24 participants

Massage To Improve Uterine Artery Blood Flow

Miguel Diego

NCT02203734

COMPLETED Phase 1 23 participants

Transforming Psychotherapy for Chronically Ill Patients

US Department of Veterans Affairs

NCT00520429

COMPLETED NA 23 participants

Synchronized Transcranial Magnetic Stimulation for PTSD

Providence VA Medical Center

NCT02981381

COMPLETED NA 23 participants

A Trial of SAMe for Treatment-Resistant Bipolar Depression

Mclean Hospital

NCT00762268

COMPLETED NA 22 participants

Supervised Treadmill Intervention to Reduce Inflammation and Depression Through Exercise in HIV: The STRIDE Pilot Study

University of Minnesota

NCT06149624

COMPLETED NA 22 participants

Personalized Depression Treatment Supported by Mobile Sensor Analytics

UConn Health

NCT06292221

COMPLETED NA 21 participants

Healthcare Providers as Trusted Messengers to Increase Receipt of Tax Credits Among Low-income Families

University of California, Los Angeles

NCT05612685

COMPLETED Phase 2 21 participants

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

NYU Langone Health

NCT02106325

COMPLETED Phase 2 21 participants

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

NCT00005850

COMPLETED NA 21 participants

Designing a Mental Health Model for Latina Women

University of New Mexi

NCT03901430

COMPLETED Phase 2 21 participants

Nitrous Oxide as Treatment for Major Depression - a Pilot Study

Washington University School of Medicine

NCT02139540

COMPLETED Phase 4 20 participants

Depression-Diabetes Mechanisms: Urban African Americans

Emory University

NCT00209170

COMPLETED Phase 2 20 participants

Trigeminal Nerve Stimulation for Depression: Dose Finding

University of California, Los Angeles

NCT01343563

COMPLETED Phase 3 20 participants

Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction

Massachusetts General Hospital

NCT00181961

COMPLETED Phase 4 20 participants

Quetiapine in Melancholic Depression

University of Cincinnati

NCT01200901

COMPLETED NA 19 participants

VOICES Socials for Older Veterans With Depression

VA Office of Research and Development

NCT06145334

COMPLETED Phase 2 19 participants

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

University of Washington

NCT00524420

COMPLETED NA 19 participants

Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women

Dartmouth-Hitchcock Medical Center

NCT02501239

COMPLETED NA 18 participants

VA Home-Based Emotional Learning With Practical Skills

Baylor College of Medicine

NCT01685528

COMPLETED Phase 4 18 participants

Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder

University of Pennsylvania

NCT00626340

COMPLETED Phase 4 18 participants

Adjunctive Transcranial Direct Current Stimulation for Cognition in Major Depression

University of California, Los Angeles

NCT00760097

COMPLETED NA 18 participants

Parenting Young Children in Pediatrics

University of Oregon

NCT06273228

COMPLETED NA 18 participants

Depression Decision Aid: Feasibility Pilot

Weill Medical College of Cornell University

NCT02239367

COMPLETED 17 participants

In Vivo Imaging of Therapeutic Electric Current Flow

University of Florida

NCT02453763

COMPLETED NA 17 participants

Traditional African Healing Ceremony in a U.S. Population

Duke University

NCT01873482

COMPLETED 17 participants

Determining Relationships Among Maternity Stress & Sleep

University of North Carolina, Chapel Hill

NCT02133963

COMPLETED NA 16 participants

Cognitive Enhancement in Depression (The COG-D Study)

Vanderbilt University Medical Center

NCT05400512

← Previous Page 13 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 41
Phase 2 70
Phase 3 29
Phase 4 41

Named interventions

Most-linked intervention names on Depression records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
29 trials
Ketamine Drug
11 trials
Escitalopram Drug
11 trials
Psilocybin Drug
8 trials
Placebo Other
8 trials
Sertraline Drug
6 trials
Cognitive Behavioral Therapy Behavioral
5 trials
Duloxetine Drug
5 trials

US sites by state

Facility locations filed on Depression trials. A trial with sites in several states counts in each.

California 116 trials
New York 88 trials
Massachusetts 70 trials
Texas 58 trials
Pennsylvania 54 trials
Florida 49 trials
Maryland 42 trials
North Carolina 38 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Depression page

687 registered trials, 245 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depression condition card totals 687 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.